The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| GLAX.F | +22.3% | +20.43% | +3.78% | +974% |
| S&P | +12.65% | +91.73% | +13.89% | +9,368% |
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Commercial Operations, Research and Development, and Consumer Healthcare. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
No news articles found for GSK.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $11.52B | 10.6% |
| Gross Profit | $8.51B | 15.1% |
| Gross Margin | 73.80% | 2.9% |
| Market Cap | $83.96B | 2.7% |
| Market Cap / Employee | $1.22M | 0.0% |
| Employees | 68.6K | -2.3% |
| Net Income | $2.89B | 3321.0% |
| EBITDA | $4.46B | 140.5% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $4.44B | 3.6% |
| Accounts Receivable | $10.69B | 7.9% |
| Inventory | 8.2K | 3.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $20.05B | 12.9% |
| Short Term Debt | $3.84B | 1.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 9.00% | 4.8% |
| Return On Invested Capital | 13.26% | -0.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $2.59B | 6.2% |
| Operating Free Cash Flow | $3.01B | 5.5% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 21.07 | 19.36 | 17.54 | 11.93 | -54.43% |
| Price to Book | 3.65 | 4.70 | 4.17 | 4.17 | -7.43% |
| Price to Sales | 1.74 | 1.94 | 1.91 | 2.07 | -1.14% |
| Price to Tangible Book Value | -6.66 | -7.29 | -6.55 | -8.42 | 4.93% |
| Price to Free Cash Flow TTM | 24.26 | 25.07 | 17.32 | 18.82 | -9.00% |
| Enterprise Value to EBITDA | 34.01 | 25.58 | 25.15 | 23.73 | -55.75% |
| Free Cash Flow Yield | 4.1% | 4.0% | 5.8% | 5.3% | 9.89% |
| Return on Equity | 19.1% | 22.3% | 23.0% | 35.6% | 95.90% |
| Total Debt | $21.27B | $23.79B | $23.78B | $23.90B | 10.93% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
